Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan

Hong Yuan Hsu, Mei Hwei Chang, Hong Nerng Ho, Rhong Phong Hsieh, Shyh Dye Lee, Ding Shinn Chen, Chin Yun Lee, Kue Hsiung Hsieh

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

To determine the HLA-linked immune response gene that controls low responsiveness to hepatitis B surface antigen (HBsAg), HLA typing was performed in 33 initial non-responders (male:female = 23:10, age 1.5-46 years) who had poor antibody response (anti-HBs < 10 mIU ml-1) after four doses of plasma-derived hepatitis B vaccine. Of 33 initial non-responders, 26 received two additional doses of either the same vaccine (n = 18) or recombinant hepatitis B vaccine (n = 8) and returned for anti-HBs measurement. At 1 month after the sixth dose, anti-HBs was still <10 mIU ml-1 in 20 cases and 10-20 mIU ml-1 in three cases. Analysis of HLA antigen frequencies in these 23 ultimate low responders revealed that nine (39%) were positive for DR14, a statistically significant association of low responsiveness to hepatitis B vaccine with HLA-DR14. In addition, 26% of the ultimate low-responders were positive for DQ3, a frequency significantly lower than the expected rate in the general population. Among the nine ultimate low-responders with DR14, seven were heterozygous for this allele, while the other two cases had a single isolated DR14; and all nine were in association with DR52. These results suggest that a DR14-DR52 association, probably dominantly expressed, may be involved in the low immune responsiveness to hepatitis B vaccine of the Chinese population in Taiwan.

Original languageEnglish
Pages (from-to)1437-1440
Number of pages4
JournalVaccine
Volume11
Issue number14
DOIs
Publication statusPublished - Jan 1 1993
Externally publishedYes

Fingerprint

Hepatitis B Vaccines
hepatitis B
Taiwan
vaccines
Histocompatibility Testing
dosage
Synthetic Vaccines
Hepatitis B Surface Antigens
HLA Antigens
Population
Antibody Formation
Vaccines
Alleles
HLA-DR14
immune response
alleles
antibodies
Genes
genes

Keywords

  • hepatitis B vaccine
  • HLA
  • non-responder

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Hsu, H. Y., Chang, M. H., Ho, H. N., Hsieh, R. P., Lee, S. D., Chen, D. S., ... Hsieh, K. H. (1993). Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan. Vaccine, 11(14), 1437-1440. https://doi.org/10.1016/0264-410X(93)90173-U

Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan. / Hsu, Hong Yuan; Chang, Mei Hwei; Ho, Hong Nerng; Hsieh, Rhong Phong; Lee, Shyh Dye; Chen, Ding Shinn; Lee, Chin Yun; Hsieh, Kue Hsiung.

In: Vaccine, Vol. 11, No. 14, 01.01.1993, p. 1437-1440.

Research output: Contribution to journalArticle

Hsu, HY, Chang, MH, Ho, HN, Hsieh, RP, Lee, SD, Chen, DS, Lee, CY & Hsieh, KH 1993, 'Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan', Vaccine, vol. 11, no. 14, pp. 1437-1440. https://doi.org/10.1016/0264-410X(93)90173-U
Hsu, Hong Yuan ; Chang, Mei Hwei ; Ho, Hong Nerng ; Hsieh, Rhong Phong ; Lee, Shyh Dye ; Chen, Ding Shinn ; Lee, Chin Yun ; Hsieh, Kue Hsiung. / Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan. In: Vaccine. 1993 ; Vol. 11, No. 14. pp. 1437-1440.
@article{b660451c60d8446bad362dec9bdf58a0,
title = "Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan",
abstract = "To determine the HLA-linked immune response gene that controls low responsiveness to hepatitis B surface antigen (HBsAg), HLA typing was performed in 33 initial non-responders (male:female = 23:10, age 1.5-46 years) who had poor antibody response (anti-HBs < 10 mIU ml-1) after four doses of plasma-derived hepatitis B vaccine. Of 33 initial non-responders, 26 received two additional doses of either the same vaccine (n = 18) or recombinant hepatitis B vaccine (n = 8) and returned for anti-HBs measurement. At 1 month after the sixth dose, anti-HBs was still <10 mIU ml-1 in 20 cases and 10-20 mIU ml-1 in three cases. Analysis of HLA antigen frequencies in these 23 ultimate low responders revealed that nine (39{\%}) were positive for DR14, a statistically significant association of low responsiveness to hepatitis B vaccine with HLA-DR14. In addition, 26{\%} of the ultimate low-responders were positive for DQ3, a frequency significantly lower than the expected rate in the general population. Among the nine ultimate low-responders with DR14, seven were heterozygous for this allele, while the other two cases had a single isolated DR14; and all nine were in association with DR52. These results suggest that a DR14-DR52 association, probably dominantly expressed, may be involved in the low immune responsiveness to hepatitis B vaccine of the Chinese population in Taiwan.",
keywords = "hepatitis B vaccine, HLA, non-responder",
author = "Hsu, {Hong Yuan} and Chang, {Mei Hwei} and Ho, {Hong Nerng} and Hsieh, {Rhong Phong} and Lee, {Shyh Dye} and Chen, {Ding Shinn} and Lee, {Chin Yun} and Hsieh, {Kue Hsiung}",
year = "1993",
month = "1",
day = "1",
doi = "10.1016/0264-410X(93)90173-U",
language = "English",
volume = "11",
pages = "1437--1440",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "14",

}

TY - JOUR

T1 - Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan

AU - Hsu, Hong Yuan

AU - Chang, Mei Hwei

AU - Ho, Hong Nerng

AU - Hsieh, Rhong Phong

AU - Lee, Shyh Dye

AU - Chen, Ding Shinn

AU - Lee, Chin Yun

AU - Hsieh, Kue Hsiung

PY - 1993/1/1

Y1 - 1993/1/1

N2 - To determine the HLA-linked immune response gene that controls low responsiveness to hepatitis B surface antigen (HBsAg), HLA typing was performed in 33 initial non-responders (male:female = 23:10, age 1.5-46 years) who had poor antibody response (anti-HBs < 10 mIU ml-1) after four doses of plasma-derived hepatitis B vaccine. Of 33 initial non-responders, 26 received two additional doses of either the same vaccine (n = 18) or recombinant hepatitis B vaccine (n = 8) and returned for anti-HBs measurement. At 1 month after the sixth dose, anti-HBs was still <10 mIU ml-1 in 20 cases and 10-20 mIU ml-1 in three cases. Analysis of HLA antigen frequencies in these 23 ultimate low responders revealed that nine (39%) were positive for DR14, a statistically significant association of low responsiveness to hepatitis B vaccine with HLA-DR14. In addition, 26% of the ultimate low-responders were positive for DQ3, a frequency significantly lower than the expected rate in the general population. Among the nine ultimate low-responders with DR14, seven were heterozygous for this allele, while the other two cases had a single isolated DR14; and all nine were in association with DR52. These results suggest that a DR14-DR52 association, probably dominantly expressed, may be involved in the low immune responsiveness to hepatitis B vaccine of the Chinese population in Taiwan.

AB - To determine the HLA-linked immune response gene that controls low responsiveness to hepatitis B surface antigen (HBsAg), HLA typing was performed in 33 initial non-responders (male:female = 23:10, age 1.5-46 years) who had poor antibody response (anti-HBs < 10 mIU ml-1) after four doses of plasma-derived hepatitis B vaccine. Of 33 initial non-responders, 26 received two additional doses of either the same vaccine (n = 18) or recombinant hepatitis B vaccine (n = 8) and returned for anti-HBs measurement. At 1 month after the sixth dose, anti-HBs was still <10 mIU ml-1 in 20 cases and 10-20 mIU ml-1 in three cases. Analysis of HLA antigen frequencies in these 23 ultimate low responders revealed that nine (39%) were positive for DR14, a statistically significant association of low responsiveness to hepatitis B vaccine with HLA-DR14. In addition, 26% of the ultimate low-responders were positive for DQ3, a frequency significantly lower than the expected rate in the general population. Among the nine ultimate low-responders with DR14, seven were heterozygous for this allele, while the other two cases had a single isolated DR14; and all nine were in association with DR52. These results suggest that a DR14-DR52 association, probably dominantly expressed, may be involved in the low immune responsiveness to hepatitis B vaccine of the Chinese population in Taiwan.

KW - hepatitis B vaccine

KW - HLA

KW - non-responder

UR - http://www.scopus.com/inward/record.url?scp=0027424902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027424902&partnerID=8YFLogxK

U2 - 10.1016/0264-410X(93)90173-U

DO - 10.1016/0264-410X(93)90173-U

M3 - Article

C2 - 8310763

AN - SCOPUS:0027424902

VL - 11

SP - 1437

EP - 1440

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 14

ER -